The independent source for health policy research, polling, and news.
1,221-1,240 of 1,325 results
Responding to a national epidemic, many state Medicaid programs are making the coverage rules for these opioid-based medicines tougher so that physicians will think twice before prescribing them. But some worry that legitimate pain patients could suffer.
Three lobbyists for every member of Congress in a push to pass a bill that increases research funding and speeds up approvals.
The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patients’ safety and doesn’t do enough to stop spiraling drug prices.
Colorado’s approval of a ballot measure sets the stage for efforts in other states.
Despite heavy opposition from the pharmaceutical industry and skepticism from policy experts, many voters see Proposition 61 as a way to protest the nation’s mounting drug prices.
The FDA’s drug-approval team is short more than 700 people and losing skilled staff members to the drug industry.
New research tracks how the widespread availability of these high-powered medications is causing a high rate of hospitalizations for opioid poisoning among children.
Majorities of Democrats, Republicans and independents support making sure high-cost drugs for chronic conditions are affordable.
Climbing drug prices are taking a toll on West Virginia's budget, some state legislators say. Expensive drugs fuel an increase in Medicaid spending, which leaves less money for schools and roads.
The plans sought to discourage costly HIV patients by not including their drug needs in formularies or requiring high cost sharing, a Harvard Law School group says in a complaint filed with HHS.
In a report out Tuesday, hospital groups said drug prices have skyrocketed since 2013, triggering a huge increase in what hospitals spend on pharmaceuticals.
KHN’s Julie Appleby joined forces with USA Today to create this chart, which details the various industry players and how they contribute to a prescription drug’s cost.
Two prescription medications have been found to be successful in helping many patients with alcohol cravings. Yet they are rarely used and many patients don’t know they exist.
Ten-year-old Josh Hardy died last month. His struggle to survive helped to spur laws to get unapproved drugs to the terminally ill.
The drug’s manufacturer says it has an expiration date of 12 to 18 months but that includes distribution time, so many customers find they have to buy a new device at least once a year.
A voucher awarded to companies that find treatments for rare childhood diseases can be sold to the highest bidder — and then used to speed up approvals for much more common drugs.
As the spiraling costs attract headlines, many people are looking to the government to rein in prescription drug prices, according to the Kaiser Family Foundation poll.
The research, published in JAMA Psychiatry, finds significant increases in the use of anti-depressants and depression diagnoses for women using hormonal forms of contraceptives, such as the pill.
Such medications account for more than a quarter of the state agency’s $2.1 billion in pharmacy costs.
Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.
© 2026 KFF